Patients with HCV-related hepatic fibrosis showed increased serum ALT levels and liver fibrosis degree (Table 1), accompanied by a parallel increase in the expression of hepatic α-SMA and COL1, and a dramatically decreased expression of hepatic GCLC (Figure 2A). The gene discussed is ACTA1; the disease is Hepatic fibrosis.